|
Report Date : |
03.12.2013 |
IDENTIFICATION DETAILS
|
Name : |
NESTELCO S.A. |
|
|
|
|
Registered Office : |
Yaguaron 1407, Torre de Los Profesionales, 11000, Montevideo |
|
|
|
|
Country : |
Uruguay |
|
|
|
|
Date of Incorporation : |
25.05.1999 |
|
|
|
|
Legal Form : |
Joint-Stock Company |
|
|
|
|
Line of Business : |
Subject is engaged in manufacture, import and export of medicinal
products in general. |
|
|
|
|
No. of Employees : |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
|
|
|
Payment Behaviour : |
Unknown |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March, 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Uruguay |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
URUGUAY - ECONOMIC OVERVIEW
Uruguay has a free market economy characterized by an export-oriented agricultural sector, a well-educated work force, and high levels of social spending. Following financial difficulties in the late 1990s and early 2000s, economic growth for Uruguay averaged 8% annually during the period 2004-08. The 2008-09 global financial crisis put a brake on Uruguay's vigorous growth, which decelerated to 2.6% in 2009. Nevertheless, the country managed to avoid a recession and keep positive growth rates, mainly through higher public expenditure and investment, and GDP growth reached 8.9% in 2010 but fell to about 3.5% in 2012, the result of a renewed slowdown in the global economy and in Uruguay's main trade partners and Common Market of the South (Mercosur) counterparts, Argentina and Brazil. Uruguay has sought to expand trade within Mercosur and with non-Mercosur members. Uruguay''s total merchandise trade with Mercosur since 2006 has increased by nearly 70% to more than $5 billion while its total trade with the world has almost doubled to roughly $20 billion.
|
Source
: CIA |
|
CORRECT COMPANY NAME |
NESTELCO S.A. |
|
TAXPAYER REGISTRATION |
RUT 214068030013 |
|
MAIN ADDRESS |
Yaguaron 1407, Torre de Los Profesionales |
|
POSTAL CODE |
11000 |
|
DEPT/PROV/REGION/STATE |
Montevideo |
|
COUNTRY |
URUGUAY |
|
TELEPHONE |
(5982) 29039245 |
|
CORPORATE E-MAIL |
gabriel.martinez@chemsys.net |
|
COMMENTS |
|
|
The heading address belongs to the Operation Headquarters. |
|
|
NOTE |
|
|
The order was requested with no address. |
|
|
|
|
|
Date of foundation |
1999 |
|
Chief Executive |
GLIKIN GELMAN, EDUARDO MARIO |
|
Disposition |
Poor. Very few information was given. Politely. |
|
Payments policy |
Without rating (No payment experience traced) |
|
Number of times that this company was required: 4 |
|
|
LEGAL STATUS |
Joint-Stock Company |
|
|
|
DATE OF INCORPORATION |
25MAY1999 |
|
|
|
PLACE OF REGISTRY |
Montevideo |
|
|
|
NOTARY OFFICE |
|
DURATION |
100 years |
|
CURRENT EXCHANGE RATE (US$) |
Ps$21.30 per US$1.= Dollar |
|
|
|
COMMENTS |
|
||
|
The DGI will register annual effective Certificate ENABLED, issued on
20/03/2013, validity 31/03/2014. |
|||
|
|
GLIKIN GELMAN, EDUARDO MARIO |
|
|
TITLE |
Chairman of Board of Dirs |
|
NATIONALITY |
Argentinian |
|
ID |
CI 5.300.549-9 |
|
BACKGROUND INFORMATION |
He has been President of Nestelco S.A. since September 22, 2008. This
is an offshore company that indirectly uses the free trade zone in the
medicines sector. |
ASSOCIATED AS PER OUR DATABASE TO
|
COMPANY |
TITLE |
TAX REG |
COUNTRY |
|
AMSKUNDE S.A. |
President |
214826220013 |
URUGUAY |
|
POCH, SUSANA |
|
|
TITLE |
Director |
|
NATIONALITY |
Argentinian |
|
|
|
SIC Classification 2 8 - CHEMICALS, PHARMACEUTICALS INDUSTRY AND ALLIED PRODUCTS.
(Manuf.Pigments, Resins, Plastics, Serums, Perfums, Paints, Fertilizers,
Explosives. Medicines.) |
|||||||||||
|
Main activity |
Subject is engaged in manufacture, import and export of medicinal
products in general. Products: Ondansetron and its salts, Alparazolam, Camazepam, Acyclic
amide, Amino acid by-products and other organic compounds. |
||||||||||
|
OPERATIONS |
|||||||||||
|
Import |
Yes |
||||||||||
|
Country |
(From Argentina, China, India, Spain, Israel, Brazil) |
||||||||||
|
ANNUAL Imports In US$ (CIF) |
|
||||||||||
|
Export |
Yes |
||||||||||
|
SELLING TerritorY |
National Market and eventually abroad |
||||||||||
|
AREA |
6,000 M2 |
|
OTHER PREMISES |
Its administrative offices operate at the heading address. OPERATIONAL OFFICES: Ruta 8 Km. 17.500
Local 207 Edif. 200, Zonamerica, Montevideo |
|
Subject imports heterocyclic compounds, structure of which has 1
oxazine cycle, medicines without antibiotics, organophosphorus compounds |
|
Disposition |
Poor. Very few information was given. Politely. |
|
Interviewee(s) |
Gabriel Martinez |
|
Position(s) |
Accountant |
|
Information provided |
He collaborated with the delivery of operational data except for
financial figures. |
|
|
|
|
|
|
|
SALES |
US$ 0.00 () |
|
FINANCIAL SITUATION |
UNDETERMINED This is a company established in 1999, with no negative history. |
(Confidential Information)
TRADE REFERENCES
|
CREDIT BUREAU COMMENTS
|
||||||||||||||||
|
SUPERINTENDENCY OF BANK & INSURANCE (SBS) |
||||||||||||||||
|
Debt structure for bank. SBS Latest Consolidated Credit Report as of :
31/07/2013 |
||||||||||||||||
|
||||||||||||||||
|
CONSOLIDATED DEBT (ALL BANKS) ENTITIES
NUMBER : 01 31/07/2013 |
||||||||||||||||
|
||||||||||||||||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.62.23 |
|
|
1 |
Rs.102.14 |
|
Euro |
1 |
Rs.84.64 |
INFORMATION DETAILS
|
Report Prepared
by : |
NNA |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to
overcome financial difficulties seems comparatively below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.